EU approves Zilver PTX drug-coated stent
Angiotech Pharmaceuticals Inc and Cook Medical’s Zilver PTX drug-coated stent has received approval for use in the European Union (EU). The device is used to prevent blockage of the superficial femoral artery, which is the main blood vessel in the thigh. The use of the stent has already started in patients.
- Drug-coated stents could boost death rate in heart attack patients
- FDA approves market launch of Boston Scientific’s DES
- FDA approves Effient for thrombotic cardiovascular
- FDA approves Cordis Cypher drug-eluting stent
